Xseer Pharmaceuticals
FDA-registered, US-based CDMO and 503B outsourcing facility providing cGMP sterile and non-sterile contract manufacturing, formulation development, in-house analytical and microbiology testing, and regulatory/CMC support for products from development through commercial supply. Operates an on-site quality unit and laboratory supporting batch release, stability, and method validation under FDA oversight.
Industries
Nr. of Employees
small (1-50)
Xseer Pharmaceuticals
1990 Westwood Blvd, Los Angeles, CA 90025 USA
Products
B-Complex 110 (injectable)
Multi-vitamin injectable combining B1, B2, B3, B5, B6 and B7 formulated for intramuscular or intravenous administration; provided with storage and handling instructions and listed contraindications/interactions.
Hydroxocobalamin (injectable)
Injectable form of vitamin B12 indicated for treatment of B12 deficiency and use as an antidote for cyanide poisoning; includes dosing guidance, contraindications, interactions, and storage recommendations.
Topical cosmetic serums, lotions and sprays (private-label)
Custom-developed topical formulations including anti-aging serums, moisturizers, wellness sprays (e.g., magnesium, vitamin D) and other label-ready topical products for private-label customers.
B-Complex 110 (injectable)
Multi-vitamin injectable combining B1, B2, B3, B5, B6 and B7 formulated for intramuscular or intravenous administration; provided with storage and handling instructions and listed contraindications/interactions.
Hydroxocobalamin (injectable)
Injectable form of vitamin B12 indicated for treatment of B12 deficiency and use as an antidote for cyanide poisoning; includes dosing guidance, contraindications, interactions, and storage recommendations.
Topical cosmetic serums, lotions and sprays (private-label)
Custom-developed topical formulations including anti-aging serums, moisturizers, wellness sprays (e.g., magnesium, vitamin D) and other label-ready topical products for private-label customers.
Services
End-to-end cGMP contract manufacturing for sterile and non-sterile drug products, from formulation through finished product supply.
Pre-formulation, formulation optimization, excipient compatibility studies and analytical method development to support regulatory submissions.
In-house analytical and microbiological testing including potency, impurities, sterility, endotoxin, bioburden, and stability studies for release and stability programs.
Private-label manufacturing, packaging, labeling and logistics support to enable direct supply to clinics and eliminate intermediary distribution costs.
CMC documentation, change control, regulatory packages and validation documentation to support product registration and regulatory inspections.
End-to-end cGMP contract manufacturing for sterile and non-sterile drug products, from formulation through finished product supply.
Pre-formulation, formulation optimization, excipient compatibility studies and analytical method development to support regulatory submissions.
In-house analytical and microbiological testing including potency, impurities, sterility, endotoxin, bioburden, and stability studies for release and stability programs.
Private-label manufacturing, packaging, labeling and logistics support to enable direct supply to clinics and eliminate intermediary distribution costs.
CMC documentation, change control, regulatory packages and validation documentation to support product registration and regulatory inspections.
Expertise Areas
- CDMO contract manufacturing
- Sterile injectable manufacturing
- Formulation development and CMC
- Analytical chemistry and stability testing
Key Technologies
- Aseptic filling (vials, prefilled syringes)
- Lyophilization
- HPLC/UPLC potency and impurity assays
- Endotoxin (LAL) assays
News & Updates
Company blog post describing quality, flexibility, and reliability as operational principles for manufacturing and service delivery.
Blog post stating the company operates a 503B outsourcing compounding facility in California and is preparing regulatory submissions for state outsourcing facility status.
Blog post outlining the company's independent quality unit, validation and testing approach, and use of HPLC and rapid microbiology testing in QA/QC workflows.
Company blog post describing quality, flexibility, and reliability as operational principles for manufacturing and service delivery.
Blog post stating the company operates a 503B outsourcing compounding facility in California and is preparing regulatory submissions for state outsourcing facility status.
Blog post outlining the company's independent quality unit, validation and testing approach, and use of HPLC and rapid microbiology testing in QA/QC workflows.